NGSX Financial Facts
Total operating expenses: 4.17MSelling, general and administrative: 2.78M
See Full Income Statement
Additional paid-in capital: 243.43M
Accumulated other comprehensive gain (loss): 1K
See Full Balance Sheet
NeurogesX (NGSX) Earnings
|
Expand Research on NGSX
Next EPS Date | N/A | EPS Growth Rate | N/A |
---|---|---|---|
Average EPS % Beat Rate | -0.9% | Revenue Growth Rate | N/A |
Average % Move 1-Wk after EPS | -5.4% | Normal Earnings Time | Before Open |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
3/8/12 | Q411 | -$0.34 | -$0.41 | +$0.07 | $2.96M | $3.01M | N/A | Details | |||
10/31/11 | Q311 | -$0.43 | -$0.44 | +$0.01 | $2.89M | $3.14M | N/A | Details | |||
8/9/11 | Q211 | -$0.81 | -$0.72 | -$0.09 | $2.5M | $3.04M | N/A | Details | |||
4/29/11 | Q111 | -$0.75 | -$0.68 | -$0.07 | $3.2M | $3.01M | N/A | Details | |||
11/3/10 | Q310 | -$0.72 | -$0.65 | -$0.07 | N/A | N/A | N/A | Details |